Press releases

Non Regulatory

November 11, 2024

Vivesto’s Paccal Vet receives Limited Market classification in EU

Regulatory

November 7, 2024

Vivesto signs Apealea option agreement with Zhida Pharmaceutical

Non Regulatory

July 1, 2024

Vivesto receives positive Cantrixil preclinical efficacy data

Regulatory

May 23, 2024

Report from Annual General Meeting in Vivesto AB

Regulatory

April 23, 2024

Notice of Annual General Meeting in Vivesto AB

Non Regulatory

March 19, 2024

Vivesto to hold live-streamed Paccal Vet R&D Update on March 26

Regulatory

March 7, 2024

Vivesto doses first patient in its clinical Paccal Vet trial

Non Regulatory

January 30, 2024

Vivesto’s international patent application for XR-18 receives positive decision